Combining any statin with a fibrate, another category of lipid-lowering drugs, increases the risks for rhabdomyolysis to almost 6.0 per 10,000 person-years.

Drugs that control different types of fats in the blood (lipid-lowering drugs) may also be needed.

Likewise, in a population-based study from the Netherlands, merely 16% of individuals eligible for lipid-lowering drugs were actually treated [7].

A lipid profile may also be ordered at regular intervals to evaluate the success of lipid-lowering drugs such as statins.

They are called lipid-lowering drugs.

But in recent years lipid-lowering drugs called statins have cornered most of the market.

Since its introduction, the price of lipid-lowering drugs and their benefits in atherosclerosis has been much debated.

Simvastatin is a powerful lipid-lowering drug that can decrease low density lipoprotein (LDL) levels by up to 50%.

After taking steps to lower cholesterol, lipid-lowering drugs should be used.

None took lipid-lowering drugs during the test.